Psyence Biomedical (PBM) EBITDA (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly EBITDA of -$752618.0 in Q3 2025, down 1898.59% quarter-over-quarter from $41845.0 in Q3 2024, and down 1898.59% on a YoY basis from $41845.0 in Q3 2024.
Psyence Biomedical (PBM) EBITDA (2023 - 2025) Analysis & Trends
Psyence Biomedical's EBITDA history runs 3 years deep, the most recent figure standing at -$752618.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 661.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -752,618.00 |
| Sep 30, 2024 | 41,845.00 |
| Mar 31, 2023 | -3.23 Mn |